Products
Bivalirudin was commercially available as a powder for preparation of a concentrate for solution for injection or infusion (Angiox). It was approved in many countries as of 2007. It has since become unavailable.
Structure and properties
Bivalirudin originated from hirudin, an anticoagulant substance found in leeches.
Effects
Bivalirudin (ATC B01AE06) has antithrombotic properties.
Indications
Anticoagulant for patients undergoing percutaneous coronary intervention (PCI).
